Enteris Biopharma, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Enteris Biopharma, Inc.

Sort by

Viewing results 1‒25 of 58

Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...Nonetheless, James Shin, a biopharma analyst at Deutsche Bank, said the sharp increase in biosimilar prescriptions in recent weeks would be “alarming” to AbbVie....
April 25, 2024
John Gapper
The painfully high price of Humira is patently wrong
...But most early stage research is done in university laboratories or at small biopharma companies. Do big companies that acquire the likely winners merit more than 20 years of patent protection?...
February 24, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Mergers & Acquisitions
Pfizer in talks to buy Global Blood Therapeutics for roughly $5bn
...The proposed transaction comes amid an apparent uptick in M&A activity across the biopharma sector, which is being driven by a combination of larger pharmaceutical companies seeking new drugs to bolster...
August 5, 2022
Pfizer Inc
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay
...The biopharma industry said the rewards were justified given the extraordinary efforts made by leaders during the pandemic in developing Covid jabs....
April 5, 2022
Johnson & Johnson Co Inc
J&J targets Chinese biotech deals as western pharma groups look east
...The market value of listed biopharma groups from China on the Hong Kong, Shanghai and Nasdaq exchanges has surged from $3bn in 2016 to $240bn today, McKinsey said — despite a sharp correction in global biotech...
March 6, 2022
Q&ADrugs research
Alzheimer’s sufferers await ruling on potential blockbuster drug
...“Without question this is the biggest binary event in biopharma in 2021,” said Colin Bristow, an analyst at UBS, referring to the drug’s approval or rejection. How does the drug work?...
June 7, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FT CollectionsAstraZeneca
Disputes leave AstraZeneca boss with chronic vaccine headache
...A person close to the company rejected that, pointing to key roles played by Mene Pangalos, head of biopharma R&D, Ruud Dobber, head of the biopharma business, and Pam Cheng, head of global operations and...
March 25, 2021
Covid-19 vaccines
EU leaders vent fears over delays to vaccination drive
...It needs more doses now — but we also need to be ready for the variants,” said Angela Hwang, president of global biopharma for Pfizer, whose vaccine developed with Germany’s BioNTech was the first to win...
February 25, 2021
Johnson & Johnson Co Inc
Johnson & Johnson to buy biotech Momenta in $6.5bn deal
...J&J’s deal follows a similar move by the French pharmaceutical group Sanofi, which on Monday said it had agreed to buy San Francisco-based Principia Biopharma in a $3.4bn deal....
August 19, 2020
AbbVie Inc
US regulator clears AbbVie’s $63bn deal for Allergan
...Other deals included Bristol-Myers-Squibb’s $74bn takeover of biotech group Celgene and Pfizer’s $11.4bn acquisition of Array BioPharma....
May 6, 2020
Gilead Sciences Inc
Gilead buys cancer therapy specialist Forty Seven in $4.9bn deal
...Early last year Bristol-Myers Squibb purchased Celgene for $93bn, while Pfizer snapped up Array BioPharma for $11bn in June....
March 2, 2020
Biopharma
Medicxi raises €400m as Europe warms up to biopharma
...Biopharma companies, which use cutting edge biology to produce innovative medicines, is risky for investors given the high failure rate that is the hallmark of drug discovery....
July 19, 2019
Pfizer Inc
Pfizer to boost cancer treatment portfolio with $11.4bn Array deal
...Pfizer has agreed to pay $11.4bn for Array BioPharma, the latest move in an arms race between large pharmaceutical groups to assemble potentially blockbuster cancer treatments....
June 17, 2019
Merck & Co Inc
Merck raises forecasts as cancer drug sales soar
...company lowered its guidance, on a gaap basis, to between $3.78 and $3.88, compared to its previous forecasts of $4.02 and $4.14, because of costs related to the acquisition of Peloton Therapeutics, a biopharma...
July 30, 2019
Pfizer Inc
Pfizer and Mylan to combine off-patent drugs businesses
...Revenue from the biopharma division rose 2 per cent year on year but sales at Upjohn dropped 11 per cent while revenue from the consumer healthcare business was down 3 per cent....
July 29, 2019
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
FT News Briefing podcast9 min listen
US-Iran, Europe’s mega funds, Pfizer cancer deal
...wealth fund is looking to ramp up its investment plans in North America and Asia, the biggest European private equity groups are rushing to raise new mega funds and Pfizer agrees to pay $11.4bn for Array BioPharma...
June 18, 2019
Pfizer Inc
Pfizer and Mylan set to merge off-patent drugs businesses
...It is also making acquisitions to bolster its position in advanced areas such as oncology, buying Array BioPharma, a Colorado-based drugmaker, in June for $10.6bn....
July 27, 2019
AbbVie Inc
AbbVie to acquire Botox maker Allergan for $63bn
...It was followed by Pfizer’s $11.4bn purchase of oncology specialist Array BioPharma and Eli Lilly’s $8bn buyout of Loxo Oncology....
June 25, 2019
Pfizer Inc
Pfizer nudges guidance higher amid strong drug sales
...The higher prices and volume growth helped power a 3 per cent rise in sales at its all important Biopharma division to $9.2bn during the first quarter....
April 30, 2019
Biotech
J&J and Novartis back cancer geneticist’s immunotherapy start-up
...Siddhartha Mukherjee, the cancer geneticist and Pulitzer Prize-winning writer who is working on a novel way to expand immunotherapies for blood cancers, has raised $42m for his start-up Vor Biopharma....
February 14, 2019
Equities
Markets Now - Monday 8th June 2020
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
June 8, 2020
Samsung BioLogics
Samsung BioLogics surges by a fifth after avoiding delisting
...Big South Korean biopharma companies have caught the attention of global investors in recent years....
December 11, 2018
Cargill Inc
Cargill announces shake-up of top management team
...Ms Richo, who most recently served as general counsel of Belgian biopharma company UCB, will become a member of the executive team and succeeds Laura Witte, who retired in May....
October 30, 2018
News in-depthPharmaceuticals sector
Investors smart at ailing pharma deals
...Target: Pharmacyclics Inc | Acquirer: AbbVie Deal value $21bn | Premium 61% No auction was more hotly contested than that of Pharmacyclics, which made a single drug, Imbruvica, for blood cancer....
April 4, 2018
News in-depthEuropean companies
Drugmakers take unorthodox route to boosting biosimilars
...Fujifilm has teamed up with a Japanese pharma company, Kyowa Hakko Kirin Biologics, and said that, by merging technologies developed through its photographic film business with Kyowa’s expertise in biopharma...
April 18, 2018

Previous pagePage 1 of 3Next page